THE EVERETT ADVOCATE – Friday, January 17, 2020 CANCER | FROM PAGE 14 in those ages 20 to 49 and one percent per year in those ages 50 to 64. Even more striking are the mortality declines of five percent to six percent in individuals 65 and older, among whom rates were previously increasing. “The news this year is mixed,” Experienced Bartender/Server wanted for restaurant in Everett Square. Call (617) 387-9810 Lawn and Yard Care SNOW PLOWING *REASONABLE RATES * PROMPT SERVICE * PARKING LOTS USA 781-521-9927 said Rebecca Siegel, MPH, coauthor of the report. “The exciting gains in reducing mortality for melanoma and lung cancer are tempered by slowing progress for colorectal, breast, and prostate cancers, which are amenable to early detection. It’s a reminder that increasing our investment in the equitable application of existing cancer control interventions, as well as basic and clinical research to further advance treatment, would undoubtedly accelerate progress against cancer.” Highlights from the report include: • The death rate for breast cancer dropped by 40 percent from 1989 to 2017. • The death rate for prostate cancer dropped by 52 percent from 1993 to 2017. • The death rate for colorectal cancer dropped by 53 percent from 1980 to 2017 among males and by 57 percent from 1969 to 2017 among females. • Decades-long rapid increases in liver cancer mortality appear to be abating in both men and women. • Cervical cancer, which is almost completely preventable, caused 10 premature deaths per week in women ages 20-39 in 2017. Other highlights include: • In 2020, 1,806,590 new cancer cases and 606,520 cancer deaths are projected to occur in the United States. • Progress for hematopoietic and lymphoid malignancies (leukemias and lymphomas) has been especially rapid due to improvements in treatment protocols, including the development of targeted therapies. The five-year relative survival Page 19 rate for chronic myeloid leukemia increased from 22 percent in the mid-1970s to 70 percent for those diagnosed during 2009 through 2015, and most patients treated with tyrosine kinase inhibitors now experience nearly normal life expectancy. Overall, the cancer incidence rate in men declined rapidly from 2007 to 2014, but stabilized through 2016, reflecting slowing declines for colorectal cancer and stabilizing rates for prostate cancer. The overall cancer incidence rate in women has remained generally stable over the past few decades because lung cancer declines have been offset by a tapering decline for colorectal cancer and increasing or stable rates for other common cancers in women. The slight rise in breast cancer incidence rates (by approximately 0.3 percent per year) since 2004 has been attributed at least in part to continued declines in the fertility rate and increased obesity, factors that may also contribute to increasing incidence for uterine cancer (1.3 percent per year from 2007-2016). Lung cancer incidence continues to decline twice as fast in men as in women, reflecting historical differences in tobacco uptake and cessation. In contrast, colorectal cancer incidence patterns are generally similar in men and women, with the rapid declines noted during the 2000s in the wake of widespread colonoscopy uptake appearing to taper in more recent years. Incidence continues to increase for cancers of the kidney, pancreas, liver and oral cavity and pharynx (among non-Hispanic whites) and melanoma of the skin. Liver cancer is increasing most rapidly, by two percent to three percent annually during 2007 through 2016, although the pace has slowed from previous years. The five-year relative survival rate for all cancers combined diagnosed during 2009 through 2015 was 67 percent overall, 68 percent in whites, and 62 percent in blacks. Cancer survival has improved since the mid-1970s for all of the most common cancers except cervical and uterine cancers. Stagnant survival rates for these cancers largely reflect a lack of major treatment advances for patients with recurrent and metastatic disease. “The accelerated drops in lung cancer mortality as well as in melanoma that we’re seeing are likely due at least in part to advances in cancer treatment over the past decade, such as immunotherapy,” said the American Cancer Society’s Chief Medical and Scientific Officer, William G. Cance. “They are a profound reminder of how rapidly this area of research is expanding, and now leading to real hope for cancer patients.” 379 Broadway Everett 617-381-9090 All occasions florist Wedding ~ Sympathy Tributes Plants ~ Dish Gardens Customized Design Work GIFT BASKETS Fruit Baskets www.EverettFlorist.net Call Driveways from $25
20 Publizr Home